Machine learning prediction and tau-based screening identifies potential Alzheimer’s disease genes relevant to immunity

Machine learning prediction and tau-based screening identifies potential Alzheimer’s disease genes relevant to immunity

Jessica Binder et al. developed a machine learning model to discover potential drug targets for Alzheimer’s disease. They validated their 20 top candidates in several in vitro models, and highlight FRRS1, CTRAM, SCGB3A1, FAM92B/CIBAR2, and TMEFF2 as potential AD risk genes.

Bibliographic Details
Main Authors:	Jessica Binder, Oleg Ursu, Cristian Bologa, Shanya Jiang, Nicole Maphis, Somayeh Dadras, Devon Chisholm, Jason Weick, Orrin Myers, Praveen Kumar, Jeremy J. Yang, Kiran Bhaskar, Tudor I. Oprea
Format:	Article
Language:	English
Published:	Nature Portfolio 2022-02-01
Series:	Communications Biology
Online Access:	https://doi.org/10.1038/s42003-022-03068-7

Similar Items

Degradation and Transmission of Tau by Autophagic-Endolysosomal Networks and Potential Therapeutic Targets for Tauopathy
by: Shanya Jiang, et al.
Published: (2020-10-01)

Proteopathic tau primes and activates interleukin-1β via myeloid-cell-specific MyD88- and NLRP3-ASC-inflammasome pathway
by: Shanya Jiang, et al.
Published: (2021-09-01)

Relevance of Phosphorylation and Truncation of Tau to the Etiopathogenesis of Alzheimer’s Disease
by: Yan Zhou, et al.
Published: (2018-02-01)

Peptide Interference with APP and Tau Association: Relevance to Alzheimer’s Disease Amelioration
by: Ruth Maron, et al.
Published: (2020-05-01)

Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events
by: Kiran Bhaskar, et al.
Published: (2014-02-01)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
by: Daniel Lamontagne-Kam, et al.
Published: (2023-07-01)

Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
by: Hamad Yadikar, et al.
Published: (2020-01-01)

Plasma tau complements CSF tau and P‐tau in the diagnosis of Alzheimer's disease
by: Silvia Fossati, et al.
Published: (2019-12-01)

Selective In Vitro and Ex Vivo Staining of Brain Neurofibrillary Tangles and Amyloid Plaques by Novel Ethylene Ethynylene-Based Optical Sensors
by: Florencia A. Monge, et al.
Published: (2023-01-01)

Toxic tau: structural origins of tau aggregation in Alzheimer's disease
by: Abdullah Al Mamun, et al.
Published: (2020-01-01)

EGCG impedes human Tau aggregation and interacts with Tau
by: Shweta Kishor Sonawane, et al.
Published: (2020-07-01)

The Impact of Muscarinic Antagonism on Psychosis-Relevant Behaviors and Striatal [<sup>11</sup>C] Raclopride Binding in Tau Mouse Models of Alzheimer’s Disease
by: Heidy Jimenez, et al.
Published: (2023-07-01)

Identification of new GLUT2-selective inhibitors through in silico ligand screening and validation in eukaryotic expression systems
by: Sina Schmidl, et al.
Published: (2021-07-01)

Fully synthetic phosphorylated Tau181, Tau217, and Tau231 calibrators for Alzheimer’s disease diagnosis
by: Xinyu Li, et al.
Published: (2024-01-01)

Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology
by: David J. Koss, et al.
Published: (2016-07-01)

Phosphorylation of tau at Y18, but not tau-fyn binding, is required for tau to modulate NMDA receptor-dependent excitotoxicity in primary neuronal culture
by: Takashi Miyamoto, et al.
Published: (2017-05-01)

CSF p-Tau levels in the prediction of Alzheimer's disease
by: Ramesh J. L. Kandimalla, et al.
Published: (2013-09-01)

Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
by: Juan Lantero-Rodriguez, et al.
Published: (2024-02-01)

Tau kinetics in Alzheimer's disease
by: Daniel B. Hier, et al.
Published: (2022-11-01)

Tau Ubiquitination in Alzheimer's Disease
by: Longfei Li, et al.
Published: (2022-02-01)

Delivery of Intravenously Administered Antibodies Targeting Alzheimer’s Disease-Relevant Tau Species into the Brain Based on Receptor-Mediated Transcytosis
by: Toshihiko Tashima
Published: (2022-02-01)

Effects of chronic noise on the corticotropin-releasing factor system in the rat hippocampus: relevance to Alzheimer’s disease-like tau hyperphosphorylation
by: Zhihui Gai, et al.
Published: (2017-12-01)

Defining the Microbial Effluxome in the content of the Host-Microbiome Interaction
by: Anastasios eIoannidis, et al.
Published: (2015-02-01)

A possible link between astrocyte activation and tau nitration in Alzheimer's disease
by: Juan F. Reyes, et al.
Published: (2008-08-01)

Saliva tau and phospho-tau-181 measured by Lumipulse in patients with Alzheimer’s disease
by: Josef Marksteiner, et al.
Published: (2022-09-01)

Staging tau pathology with tau PET in Alzheimer’s disease: a longitudinal study
by: Shi-Dong Chen, et al.
Published: (2021-09-01)

Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer's diseases.
by: Valeriy Duka, et al.
Published: (2013-01-01)

Synaptic Tau Seeding Precedes Tau Pathology in Human Alzheimer's Disease Brain
by: Sarah L. DeVos, et al.
Published: (2018-04-01)

PHF-Core Tau as the Potential Initiating Event for Tau Pathology in Alzheimer’s Disease
by: Nabil Itzi Luna-Viramontes, et al.
Published: (2020-09-01)

Measurements of the tau mass and the mass difference of the tau(+) and tau(-) at BABAR
by: Aubert, B, et al.
Published: (2009)

Measurements of the tau mass and the mass difference of the tau+ and tau- at BABAR
by: Fisher, Peter H., et al.
Published: (2010)

Detection of Alzheimer’s disease (AD) specific tau pathology with conformation-selective anti-tau monoclonal antibody in co-morbid frontotemporal lobar degeneration-tau (FTLD-tau)
by: Garrett S. Gibbons, et al.
Published: (2019-03-01)

18F‐AV‐1451 and CSF T‐tau and P‐tau as biomarkers in Alzheimer's disease
by: Niklas Mattsson, et al.
Published: (2017-09-01)

Principal components of tau positron emission tomography and longitudinal tau accumulation in Alzheimer’s disease
by: Hanna Cho, et al.
Published: (2020-09-01)

A non-canonical role for the autophagy machinery in anti-retroviral signaling mediated by TRIM5α.
by: Bhaskar Saha, et al.
Published: (2020-10-01)

Detecting trends in the quality and productivity of grasslands by analyzing the historical vegetation relevés: A case study from Southeastern Carpathians, Vlădeasa Mountains (Romania)
by: Teodor MARUȘCA, et al.
Published: (2021-08-01)

Prefibrillar Tau oligomers alter the nucleic acid protective function of Tau in hippocampal neurons in vivo
by: Marie Violet, et al.
Published: (2015-10-01)

LHC tau-pair production constraints on $a_\tau$ and $d_\tau$
by: Ulrich Haisch, Luc Schnell, Joachim Weiss
Published: (2024-02-01)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
by: Sheelakumari Raghavan, et al.
Published: (2022-02-01)

Altered ribosomal function and protein synthesis caused by tau
by: Harrison Tudor Evans, et al.
Published: (2021-06-01)